Cargando…
Isoliquiritigenin attenuates neuroinflammation in mice model of Parkinson’s disease by promoting Nrf2/NQO-1 pathway
Parkinson’s disease (PD) is a common neurodegenerative disease that severely affects the quality of life of patients. There is no specific drug for PD up to now. Previous studies have shown that neuroinflammation plays an important role in the pathogenesis of PD. Isoliquiritigenin (ILG) is thought t...
Autores principales: | Huang, Lijuan, Han, Yan, Zhou, Qingmin, Sun, Zhihao, Yan, Jianhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468679/ https://www.ncbi.nlm.nih.gov/pubmed/36160039 http://dx.doi.org/10.1515/tnsci-2022-0239 |
Ejemplares similares
-
Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice
por: Du, Fen, et al.
Publicado: (2016) -
Isoliquiritigenin Ameliorates Ischemia-Induced Myocardial Injury via Modulating the Nrf2/HO-1 Pathway in Mice
por: Yao, Deshan, et al.
Publicado: (2022) -
Oltipraz Prevents High Glucose-Induced Oxidative Stress and Apoptosis in RSC96 Cells through the Nrf2/NQO1 Signalling Pathway
por: Jiang, Zengxin, et al.
Publicado: (2020) -
Isoliquiritigenin Ameliorates Acute Pancreatitis in Mice via Inhibition of Oxidative Stress and Modulation of the Nrf2/HO-1 Pathway
por: Liu, Xinnong, et al.
Publicado: (2018) -
Isoliquiritigenin Confers Neuroprotection and Alleviates Amyloid-β42-Induced Neuroinflammation in Microglia by Regulating the Nrf2/NF-κB Signaling
por: Fu, Yue, et al.
Publicado: (2021)